Matrix metalloproteinase-2 Conditions Human Dendritic Cells to Prime Inflammatory T(H)2 Cells via an IL-12- And OX40L-dependent Pathway - Archive ouverte HAL Access content directly
Journal Articles Cancer Cell Year : 2011

Matrix metalloproteinase-2 Conditions Human Dendritic Cells to Prime Inflammatory T(H)2 Cells via an IL-12- And OX40L-dependent Pathway

(1) , (1) , (2) , (1) , (1) , (2) , (2) , (1) , (2) , (1)
1
2

Abstract

Matrix metalloproteinase-2 (MMP-2) is a proteolytic enzyme degrading the extracellular matrix and overexpressed by many tumors. Here, we documented the presence of MMP-2-specific CD4(+) T cells in tumor-infiltrating lymphocytes (TILs) from melanoma patients. Strikingly, MMP-2-specific CD4(+) T cells displayed an inflammatory T(H)2 profile, i.e., mainly secreting TNF-α, IL-4, and IL-13 and expressing GATA-3. Furthermore, MMP-2-conditioned dendritic cells (DCs) primed naïve CD4(+) T cells to differentiate into an inflammatory T(H)2 phenotype through OX40L expression and inhibition of IL-12p70 production. MMP-2 degrades the type I IFN receptor, thereby preventing STAT1 phosphorylation, which is necessary for IL-12p35 production. Active MMP-2, therefore, acts as an endogenous type 2 "conditioner" and may play a role in the observed prevalence of detrimental type 2 responses in melanoma.
Embargoed file
Embargoed file
Ne sera jamais visible
Loading...

Dates and versions

inserm-02483749 , version 1 (18-02-2020)

Identifiers

Cite

Emmanuelle Godefroy, Olivier Manches, Brigitte Dréno, Tsivia Hochman, Linda Rolnitzky, et al.. Matrix metalloproteinase-2 Conditions Human Dendritic Cells to Prime Inflammatory T(H)2 Cells via an IL-12- And OX40L-dependent Pathway. Cancer Cell, 2011, 19 (3), pp.333-346. ⟨10.1016/j.ccr.2011.01.037⟩. ⟨inserm-02483749⟩
16 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More